Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Change in Receivables (2017 - 2026)

Sensus Healthcare has reported Change in Receivables over the past 9 years, most recently at -$3.3 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 218.95% year-over-year to -$3.3 million; the TTM value through Dec 2025 reached -$13.6 million, down 248.18%, while the annual FY2025 figure was -$13.6 million, 248.18% down from the prior year.
  • Change in Receivables for Q4 2025 was -$3.3 million at Sensus Healthcare, down from -$3.2 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $10.0 million in Q4 2022 and troughed at -$8.1 million in Q4 2021.
  • A 5-year average of -$710100.0 and a median of -$1.5 million in 2024 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 667.86% in 2022 and fell as far as 671.57% in 2022.
  • Year by year, Change in Receivables stood at -$8.1 million in 2021, then skyrocketed by 223.45% to $10.0 million in 2022, then crashed by 62.56% to $3.8 million in 2023, then dropped by 26.37% to $2.8 million in 2024, then tumbled by 218.95% to -$3.3 million in 2025.
  • Business Quant data shows Change in Receivables for SRTS at -$3.3 million in Q4 2025, -$3.2 million in Q3 2025, and -$5.4 million in Q2 2025.